Imaging of Status Epilepticus
Journal of Clinical Medicine · 23.04.2025 · 14 (9) · 2922
DOI: 10.3390/jcm14092922 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.04.2025. Verfasst von Pilar Bosque Varela und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Neurocritical Care and Neurorehabilitation, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Member…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds zur Förderung der wissenschaftlichen Forschung (FWF), Austrian Science Fund.
Abstract (Originalsprache)
MRI plays an increasingly important role in the diagnosis of status epilepticus (SE). Approximately half of patients with SE do not have pre-existing epilepsy, and the cause of de novo SE is frequently unknown. The role of MRI in the identification of causes of SE is invaluable. MRI is often helpful as a diagnostic tool in cases of non-convulsive status epilepticus (NCSE) with ambiguous EEG findings. Thus, MRI is recommended for all patients presenting with de novo SE, patients with known epilepsy with the first episode of SE and NCSE with equivocal EEG. Different peri-ictal MRI (PMA) alterations may be seen during ongoing SE or briefly after its cessation. They commonly present as peri-ictal hyper-perfusion, diffusion restriction and/or FLAIR-hyperintensity affecting specific brain areas such as the cortex, hippocampus, pulvinar of the thalamus, splenium of the corpus callosum, claustrum or cerebellum, frequently in combination, suggesting the existence of a “status epilepticus network”. MRI sequences, which are necessary for detecting PMA, include diffusion-weighted imaging, fluid attenuated inversion recovery, T1-weighted imaging with and without contrast application, as well as perfusion sequences such as arterial spin labeling. Recent research suggests that they may serve as biomarkers for predicting an outcome in SE. Patients with PMA seem to have a higher mortality rate compared to those without PMA. However, there is still a substantial knowledge gap and there are many open questions related to imaging in SE. Further prospective quantitative MRI studies with uniform protocols, timing and follow-up periods are needed to answer these important and clinically relevant questions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Neurocritical Care and Neurorehabilitation, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Member of the European Reference Network EpiCARE, Paracelsus Medical Univers…
- Department of Neuroradiology, Christian Doppler University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria.
- Department of Neurology, Hietzing Hospital and Neurological Center Rosenhügel, 1130 Vienna, Austria.
- Neuroscience Institute, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, 5020 Salzburg, Austria.
- Karl Landsteiner Institute for Neurorehabilitation and Space Neurology, 5020 Salzburg, Austria.
ORCID-Profile: Pilar Bosque Varela, Lukas Machegger, Bernardo Crespo Pimentel, Giorgi Kuchukhidze
Förderung
- Fonds zur Förderung der wissenschaftlichen Forschung (FWF), Austrian Science Fund
Zitieren
APA
Bosque Varela, P., Machegger, L., Crespo Pimentel, B., & Kuchukhidze, G. (2025). Imaging of Status Epilepticus. Journal of Clinical Medicine, 14(9), 2922. https://doi.org/10.3390/jcm14092922
Vancouver
Bosque Varela P, Machegger L, Crespo Pimentel B, Kuchukhidze G. Imaging of Status Epilepticus. Journal of Clinical Medicine. 2025;14(9):2922. doi:10.3390/jcm14092922
BibTeX
@article{BosqueVarela2025,
author = {Bosque Varela, Pilar and Machegger, Lukas and Crespo Pimentel, Bernardo and Kuchukhidze, Giorgi},
title = {Imaging of Status Epilepticus},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {9},
pages = {2922},
doi = {10.3390/jcm14092922}
}
EUVIMED